Reconstituting Immunity Post Transplant

H6676: Administration of EBV specific Cytotoxic T Lymphocytes to Recipients of Mismatched-related or Phenotypically Similar Unrelated Donor Marrow Grafts: This study uses allogeneic EBV specific T-Lymphocytes to prevent or treat EBV related infection following an allogeneic stem cell transplant.

H12683: Virus Specific Cytotoxic T-Lymphocytes for the Prophylaxis of CMB after  Allogeneic Stem Cell Transplant: A Dose-Finding Trial: This study uses allogeneic CMV specific T-Lymphocytes to prevent CMV related infection following an allogeneic stem cell transplant. 

H14097: Administration of Virus-specific Cytotlxic T–Lymphocytes for the Prophylaxis and Therapy of Adenovirus Infection Post Allogeneic Ztem Cell Transplant: This study uses allogeneic Adv (adenoviral) specific T-Lymphocytes to prevent or treat AdV related infection following an allogeneic stem cell transplant.

©2002, Cell And Gene Therapy, Baylor College of Medicine
One Baylor Plaza, N1002, Houston, TX 77030, (713)798-1246
URL: http://www.bcm.edu/genetherapy Email:cagt@bcm.edu
(Modified: September 21st, 2007 - jb)